Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Other financing activities (2024 - 2025)

Nuvation Bio (NUVB) has disclosed Other financing activities for 3 consecutive years, with $11.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Other financing activities rose 46.72% to $11.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.9 million, a 30.67% decrease, with the full-year FY2025 number at $11.9 million, down 30.67% from a year prior.
  • Other financing activities was $11.2 million for Q4 2025 at Nuvation Bio, up from $166000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $11.2 million in Q4 2025 to a low of -$3000.0 in Q4 2023.
  • A 3-year average of $4.2 million and a median of $3.2 million in 2024 define the central range for Other financing activities.
  • Peak YoY movement for Other financing activities: surged 254533.33% in 2024, then tumbled 97.37% in 2025.
  • Nuvation Bio's Other financing activities stood at -$3000.0 in 2023, then soared by 254533.33% to $7.6 million in 2024, then soared by 46.72% to $11.2 million in 2025.
  • Per Business Quant, the three most recent readings for NUVB's Other financing activities are $11.2 million (Q4 2025), $166000.0 (Q2 2025), and $534000.0 (Q1 2025).